NCT03719560View on ClinicalTrials.gov

Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 1, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2025

Conditions
Diffuse Large B Cell Lymphoma
Interventions
DRUG

Methotrexate

Systemic methotrexate

DRUG

Cytarabine

Systemic cytarabine

Trial Locations (1)

02903

Roxanne Wood, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
lead

Brown University

OTHER

NCT03719560 - Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma | Biotech Hunter | Biotech Hunter